Biomarkers clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
The HEP2 study is designed to better understand the challenges of living with focal seizures that do not respond to medication, by following 205 people with medication-resistant focal epilepsy over two years to measure changes in health status, healthcare costs, quality of life, and biomarkers of epilepsy severity and treatment response.
San Francisco, California and other locations